The BMI thresholds
FDA labeling for GLP-1 medications approved for chronic weight management (Wegovy and Zepbound) covers adults with:
- BMI of 30 or higher, or
- BMI of 27 or higher plus at least one weight-related condition.
BMI is your weight in kilograms divided by your height in meters squared. For example, someone who is 5'6" reaches a BMI of 27 at about 168 lb and a BMI of 30 at about 186 lb.
Weight-related conditions that may qualify
- High blood pressure
- Type 2 diabetes or prediabetes
- High cholesterol or triglycerides
- Obstructive sleep apnea
- Cardiovascular disease
Reasons a provider may say no
GLP-1 medications are generally not prescribed if you:
- are pregnant, planning pregnancy or breastfeeding;
- have a personal or family history of medullary thyroid cancer or MEN 2;
- have had pancreatitis, or have certain severe digestive conditions;
- have a history of serious allergic reaction to a GLP-1.
Your provider will also review other medications — especially insulin or sulfonylureas, which can raise the risk of low blood sugar — and conditions such as kidney disease or a history of eating disorders.
How the decision is made
Eligibility isn't just a number. A licensed provider looks at your BMI, health history, medications, goals and safety factors together. If medication isn't right for you, a good program will tell you why and suggest other options.
Check your eligibility with EdenRx
If you live in Florida or New York, you can complete EdenRx's free online assessment in a few minutes. Our medical team under Dr. Jean-Yves Dastain, MD reviews every assessment, typically within 24–48 hours, and you only pay if you're approved. Read more about who qualifies for weight-loss medication and our programs.
This article is for education only and is not medical advice.
